Role of advanced respiratory support in acute respiratory failure in clinically frail patients with COVID-19

Background: The main aim of this study was to assess the efficacy of advanced respiratory support (ARS) for acute respiratory failure in do-not-attempt cardiopulmonary resuscitation order (DNACPR) COVID-19 patients. Methods: In this single-center study, the impact of different types of ARS modality,...

Descripción completa

Detalles Bibliográficos
Autores principales: Nadeem, Iftikhar, Jordon, Louise, Rasool, Masood Ur, Mahdi, Noor, Kumar, Ritesh, Rehman, Zahra, Tilley, Craig J, Kang, Simran, Rai, Amrita, Lok, She, McMillan, Alison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734119/
https://www.ncbi.nlm.nih.gov/pubmed/34915735
http://dx.doi.org/10.2217/fmb-2021-0226
Descripción
Sumario:Background: The main aim of this study was to assess the efficacy of advanced respiratory support (ARS) for acute respiratory failure in do-not-attempt cardiopulmonary resuscitation order (DNACPR) COVID-19 patients. Methods: In this single-center study, the impact of different types of ARS modality, PaO(2)/FiO(2) (PF) ratio, clinical frailty score (CFS) and 4C score on mortality was evaluated. Results: There was no significant difference in age, type of ARS modality, PF ratio and 4C scores between those who died and those who survived. Overall survival rates/hospital discharge of patients still requiring ARS at 5 and 7 days post admission were 20 and 17%, respectively. Conclusion: Our study showed that ARS can be a useful tool in frail, elderly and high-risk COVID-19 patients irrespective of high 4C mortality score.

Ejemplares similares